PTC Therapeutics to Present Recent Data for Sepiapterin at t

- Results from the APHENITY trial in PKU and long-term extension study including Phe tolerance to be highlighted -

Related Keywords

Israel , Jerusalem , Israel General , Al Hafid , Dulcin Hall , Kylie Okeefe , Jeanine Clemente , Therapeutics Inc , Nasdaq , Inborn Errors , Annual Symposium , Oral Sepiapterin , Parallel Session , Term Study Design , More Information , Private Securities Litigation Reform Act , Annual Report , Genet Metab , Accessed October , Region ,